A practical synthesis of (S)-(-)-nadifloxacin: Novel acid-catalyzed racemization of tetrahydroquinaldine derivative

被引:0
作者
Hashimoto, K
Okaichi, Y
Nomi, D
Miyamoto, H
Bando, M
Kido, M
Fujimura, T
Furuta, T
Minamikawa, J
机构
[1] OTSUKA PHARMACEUT CO LTD, MICROBIOL RES INST, TOKUSHIMA 77101, JAPAN
[2] OTSUKA PHARMACEUT CO LTD, TOKUSHIMA INST NEW DRUG RES 2, TOKUSHIMA 77101, JAPAN
关键词
(S)-(-)-nadifloxacin; antibacterial agent; optical resolution; acidic racemization; tetrahydroquinaldine;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
(S)-(-)-Nadifloxacin [(S)-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, (S)-(-)-OPC-7251], an antibacterial agent, was synthesized from (S)(-)-5,6-difluoro-2-methyl-1,2,3,4-tetrahydroquinoline (DFTQ), which was prepared by the optical resolution of racemic DFTQ with 2,3-di-O-benzoyl-L-tartaric acid. Racemization of the undesired enantiomer [(R)-(+)-DFTQ] was studied in the presence of various acids and the best result was obtained in the case of methanesulfonic acid, The absolute configuration of(-)-nadifloxacin was determined as S by X-ray crystallographic analysis.
引用
收藏
页码:642 / 645
页数:4
相关论文
共 11 条
[1]  
[Anonymous], 1964, INT TABLES XRAY CRYS, V4
[2]  
*CHEM SOC JAP, 1989, GAK PUBL CTR, V6
[3]  
ISHIKAWA H, 1989, CHEM PHARM BULL, V37, P2103
[4]  
KAWASAKI K, 1990, Patent No. 2188589
[5]   CLINICAL AND BACTERIOLOGICAL EVALUATION OF OPC-7251 IN PATIENTS WITH ACNE - A DOUBLE-BLIND GROUP COMPARISON STUDY VERSUS CREAM BASE [J].
KUROKAWA, I ;
AKAMATSU, H ;
NISHIJIMA, S ;
ASADA, Y ;
KAWABATA, S .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (04) :674-681
[6]   AN EFFICIENT SYNTHESIS OF A KEY INTERMEDIATE TOWARDS (S)-(-)-NADIFLOXACIN [J].
MORITA, S ;
OTSUBO, K ;
MATSUBARA, J ;
OHTANI, T ;
UCHIDA, M .
TETRAHEDRON-ASYMMETRY, 1995, 6 (01) :245-254
[7]  
TAKADA S, 1990, Patent No. 2188570
[8]  
TAKANASHI K, Patent No. 62190166
[9]  
1982, Patent No. 5785384
[10]  
1985, TEXSAN TEXRAY STRUCT